Julian Bailes

Direttore Tecnico/Scientifico/R&S presso BLUE WATER VENTURES INTERNATIONAL, INC.

Health Technology

Commercial Services

Posizioni attive di Julian Bailes

Società	Posizione	Inizio	Fine
BLUE WATER VENTURES INTERNATIONAL, INC.	Direttore/Membro del Consiglio	-	-
BLUE WATER VENTURES INTERNATIONAL, INC.	Direttore Tecnico/Scientifico/R&S	-	-
Psycheceutical, Inc. Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021.	Direttore/Membro del Consiglio	10/01/2023	-
	Direttore Tecnico/Scientifico/R&S	10/01/2023	-

Distribuzione geografica

Stati Uniti

Posizioni

Director/Board Member	2
Chief Tech/Sci/R&D Officer	2

Settori

Health Technology	2
Commercial Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
BLUE WATER VENTURES INTERNATIONAL, INC.	Commercial Services

Aziende private	1
Psycheceutical, Inc. Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021.	Health Technology

Aziende private

Health Technology